A contrasting NMA included only RCTs involving SGLT2i (three RCTs; 2,455 participants). This study found no significant difference between dapagliflozin 10 mg daily and empagliflozin 25 mg daily in ...
Already the go-to drug of choice for millions with type 2 diabetes, metformin might also fight lung cancer if those patients have it as well, new research shows. Metformin appears to help boost ...
The Metformin for Abdominal Aortic Aneurysm Growth Inhibition (MAAAGI) trial has been testing whether the world’s most common antidiabetic drug, metformin, can stop aneurysm growth or even ...
Jardiance fended off increased competition from AstraZeneca’s Farxiga (dapagliflozin) with a 39% gain to $268 million, although it could face more pressure this year thanks to a recent approval ...
Metformin use was associated with longer overall survival in a cohort of patients with non-small cell lung cancer and the subgroup of patients with a BMI of 25 or higher but not in patients with a BMI ...
Credit: Getty Images Researchers assessed the impact of metformin on the symptoms of Sjögren syndrome. Treatment with metformin was associated with improvements in the symptoms of Sjögren syndrome.